Circadin Is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for Up to 3 Months

Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months
Çѹ·Õè 5 ¡Ã¡®Ò¤Á 2553 10:29 ¹. Neurim Pharmaceuticals (http://www.Neurim.com) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months).
Read more on Thaipr.net

Calls for 24-hour stroke hotline to be rolled out across Scotland
A 24-HOUR hotline to deal with patients suffering symptoms of a stroke has dramatically cut delays to treatment and should be rolled out across Scotland, experts believe.
Read more on The Scotsman

The £2-a-day hayfever ‘cure’ that’s too expensive for the NHS
Millions of hayfever sufferers are being denied a new treatment which could cure the condition because of a lack of NHS funds.
Read more on Evening Standard